California Baptist University
Riverside, California, 92504, United States
NCT Number: NCT06629337
It was hypothesized that aerobic exercise with blood flow restriction (BFR) induced post exercise hypotension (PEH), and the reduction in blood pressure (BP) was due to peripheral vasodilation via the histamine receptors. Ten male participants participated in this study. The participants were randomly assigned to walk for 10 minutes at 6.4 k/m, 0% grade with or without BFR after taking histamine receptor blockade. Following exercise, BP was measured at 10 min interval for 60 minutes. Heart rate (HR), stroke volume (SV), cardiac output (CO), mean arterial pressure (MAP), and total peripheral resistance (TPR) were evaluated.
Looking for future studies?
Notify Me18 year–30 year
Male
Interventional
Not applicable
Riverside, California, 92504, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Subjects ingested fexofenadine (540 mg, tablet) at least 50 minutes before and famotidine (40 mg, tablet) 1 hour 50 minutes before the onset of each protocol because these dose of oral fexofenadine and famotidine reaches its peak concentration at around 1 h and 2 h, respectively
Time frame: 10 min, 20 min, 30 min, 40 min, 50 min, and 60 min post exercise
Blood pressure change during 60 min (10 min interval) after BFR exercise
California Baptist University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07692971
Cardiovascular Diseases, Hypertension
View Trial DetailsNCT06360536
Body Weight, Cardiovascular Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT06669715
Body Weight, Cardiovascular Diseases
Ljubljana, Slovenia
View Trial DetailsNCT07048509
Cardiovascular Diseases, Healthy
Ljubljana, Slovenia
View Trial Details